After biotech stocks surged during Thursday’s trading session, Jefferies analyst Maury Raycroft assumed coverage on 6 biotech names he sees as undervalued.
While biotech stocks are extremely volatile, these stocks should present a longer-term growth opportunity for investors, according to Raycroft.
6 Biotech Stocks At Buy
1. Abeona Therapeutics Inc ABEO; $22 price target.
“Abeona’s lead ABO-102 is on an expedited path to regulatory approval in MPS IIIA, and their EB gene therapy program is another shot on goal.”
2. Alnylam Pharmaceuticals, Inc. ALNY; $102 price target.
“Optimally suited for approval in FAP with potential broader use; also, differentiated in hemophilia, acute hepatic porphyrias, and PCSK9 inhibition.”
3. Atara Biotherapeutics Inc ATRA; $30 price target.
“On-track to start their ATA129 ph.IIIs in EBV-PTLD in 2H17, which will remove a major overhang, and we believe the trial also has a good chance to succeed.”
4. Intellia Therapeutics Inc NTLA; $36 price target.
“We see potential in diverse, large market disease areas. As NTLA continues to optimize translating their technology/platform to the clinic, we believe they will gain in value and appeal to larger biotech/pharma.”
5. Ignyta Inc RXDX; $27 price target.
“The drug has differentiated CNS activity, which we believe can make it a preferred agent in a proportion of ROS1 NSCLC pts.”
6. Sangamo Therapeutics Inc SGMO; $17 price target.
“Impressive showing at ASGCT positively influenced our view on the stock. Technology also has been recently validated by PFE, and they are in the lead developmentally with programs in the clinic.”
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.